Skip to main content

#153753

Human Vaginal Epithelial Cell (HVEC) Line

Cat. #153753

Human Vaginal Epithelial Cell (HVEC) Line

Cat. #: 153753

Unit size: 1x10^6 cells / vial

Availability: 8-10 weeks

Organism: Human

Tissue: Vaginal Epithelium

Disease: S. aureus infectioni

Model: Immortalised Line

£575.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Aloysius Klingelhutz

Institute: The University of Iowa

Primary Citation: Peterson et al. 2005. ASM Journals. Infect Immun. 2005 Apr;73(4):2164–2174. PMID: 15784559

Tool Details
Target Details
Handling
References
Documentation

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Human Vaginal Epithelial Cell (HVEC) Line
  • Alternate name: HVEC E6/E7/TERT cells (V428)
  • Organism: Human
  • Tissue: Vaginal Epithelium
  • Disease: S. aureus infectioni
  • Growth properties: Adherent
  • Model: Immortalised Line
  • Conditional: No
  • Description: Immortalized HVEC line derived from primary normal human epithelial cells isolated from premenopausal vaginal hysterectomy tissue, obtained from a healthy female donor. This cell line maintains phenotype with time in culture and exhibits proinflammatory responses, and is useful for researchers studying cancer/infection biology and pathogenesis.
  • Production details: Primary normal human epithelial cells were isolated from premenopausal vaginal hysterectomy tissue, obtained from a woman who did not have cancer. Cells were grown in keratinocyte serum-free medium (KSFM) (Gibco) on plastic and passaged with a 1:4 split using trypsin-EDTA. Early-passage cells were doubly transduced with retroviruses expressing human papillomavirus 16 (HPV-16) E6/E7 and the reverse transcriptase component of telomerase, hTERT, and selected with 50 μg of the antibiotic G418 per ml (Sigma). The E6/E7/TERT cells (V428) had high levels of telomerase and became immortal without a crisis, whereas normal un-transduced cells senesced around passage 9.
  • Biosafety level: 2

Target Details

  • Target: Used to assess affects of toxins/pathogen on vaginal epithelium

Handling

  • Format: Frozen
  • Growth medium: Keratinocyte serum-free medium (KSFM) (GibcoTM), supplemented with 25 ug/ml bovine pituitary extract (BPE) and 0.16 ng/ml epidermal growth factor (EGF) and a 2% final volume of penicillin-streptomycin-amphotericin B. Do not keep media for more than 1 month past adding supplements. Do not freeze and thaw medium.
  • Temperature: 37°C
  • Unit size: 1x10^6 cells / vial
  • Shipping conditions: Dry ice
  • Subculture routine: Split 1:4 every 4-5 days at 70-90% confluency. Aspirate medium and wash plate with (1X) PBS (without calcium or magnesium). Add 4 ml (0.05%) Trypsin/EDTA and incubate at 37°C for 5-10 minutes. Add 4 ml PBS-A containing 2% FBS to inactivate the trypsin. Transfer cells to a sterile 15ml tube and centrifuge at 1200 rpm for 5min. Carefully aspirate supernatant taking care not to disturb the pellet and resuspend in K-SFM. Change media every other day. The cells will not do well if they are left over the weekend without a media change or if they are left to grow to greater than 95% confluency. Please also see detailed protocol within the Product Datasheet in the Documentation section below.

References

  • Peterson et al. 2005. ASM Journals. Infect Immun. 2005 Apr:73(4):2164–2174. PMID:15784559

Documentation

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.